Nabumetone and Lotemax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nabumetone (nabumetone) and Lotemax (loteprednol etabonate). Common drug interactions include fatigue among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Nabumetone and Lotemax. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Nabumetone?

Nabumetone has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 9,554 Nabumetone users. Check the latest studies of Nabumetone.

What is Lotemax?

Lotemax has active ingredients of loteprednol etabonate. It is often used in inflammation. eHealthMe is studying from 4,431 Lotemax users. Check the latest studies of Lotemax.

On Jul, 17, 2026

25 people who take Nabumetone and Lotemax together, and have interactions are studied.

Nabumetone and Lotemax drug interactions.

What are the common drug interactions of Nabumetone and Lotemax, by gender? *:

female:

Fatigue (feeling of tiredness)
Electrocardiogram qt prolonged
Eyelid irritation
Arthropathy
Eye pruritus (eye itching)
Impaired work ability
Pruritus (severe itching of the skin)
Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
Asthenia (weakness)
Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)

male:

Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Vomiting
Anxiety
Emotional distress
Fatigue (feeling of tiredness)
Chronic kidney disease
Dysgeusia (disorder of the sense of taste)

What are the common drug interactions of Nabumetone and Lotemax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Fatigue (feeling of tiredness)
Renal failure (kidney dysfunction)

60+:

Fatigue (feeling of tiredness)
Electrocardiogram qt prolonged
Chronic kidney disease
Headache (pain in head)
Hypermetropia (abnormal condition in which vision for distant objects is better than for near objects)
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nausea (feeling of having an urge to vomit)
Presbyopia (a condition in which the lens of the eye loses its ability to focus, making it difficult to see objects up close)
Chills (felling of cold)

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 24.00%
High Blood Cholesterol: 5 people, 20.00%
Pain: 5 people, 20.00%
Blood Pressure Abnormal: 4 people, 16.00%
Post Polio Syndrome: 4 people, 16.00%
Depression: 4 people, 16.00%
Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 12.00%
Infection: 3 people, 12.00%
Bacterial Infection: 3 people, 12.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nabumetone and Lotemax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously